Search research articles
Contact Us
Filters
Showing results (271-280 of 305) with videos related to
Page
of 31
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2021
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
Michael A Vogelbaum, Paul D Brown, Hans Messersmith, et al.
Neuro-Oncology
|
November 1, 2021
EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults
Didier Frappaz, Girish Dhall, Matthew J Murray, et al.
The Lancet. Oncology
|
January 6, 2018
Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group
D Ross Camidge, Eudocia Q Lee, Nancy U Lin, et al.
The Lancet. Oncology
|
December 19, 2015
Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group
Isabelle Thibault, Eric L Chang, Jason Sheehan, et al.
Journal of Neuro-Oncology
|
October 23, 2014
Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas
Andrew D Norden, David Schiff, Manmeet S Ahluwalia, et al.
Neuro-Oncology
|
March 29, 2018
Population description and clinical response assessment for spinal metastases: part 2 of the SPIne response assessment in Neuro-Oncology (SPINO) group report
Ilya Laufer, Simon S Lo, Eric L Chang, et al.
Journal of Neuro-Oncology
|
March 20, 2012
Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study
Whitney B Pope, Xin Joe Qiao, Hyun J Kim, et al.
Neuro-Oncology
|
July 18, 2020
CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design
Kurt A Jaeckle, Karla V Ballman, Martin van den Bent, et al.
Biorxiv : the Preprint Server for Biology
|
April 16, 2025
Discovery and therapeutic exploitation of Master Regulatory miRNAs in Glioblastoma
Shekhar Saha, Ying Zhang, Myron Keith Gibert, et al.
The New England Journal of Medicine
|
February 21, 2014
A randomized trial of bevacizumab for newly diagnosed glioblastoma
Mark R Gilbert, James J Dignam, Terri S Armstrong, et al.
Page
of 31
Search research articles
Search
Showing results (271-280 of 305) with videos related to
Sort By:
Page
of 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2021
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
Michael A Vogelbaum, Paul D Brown, Hans Messersmith, et al.
Neuro-Oncology
|
November 1, 2021
EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults
Didier Frappaz, Girish Dhall, Matthew J Murray, et al.
The Lancet. Oncology
|
January 6, 2018
Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group
D Ross Camidge, Eudocia Q Lee, Nancy U Lin, et al.
The Lancet. Oncology
|
December 19, 2015
Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group
Isabelle Thibault, Eric L Chang, Jason Sheehan, et al.
Journal of Neuro-Oncology
|
October 23, 2014
Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas
Andrew D Norden, David Schiff, Manmeet S Ahluwalia, et al.
Neuro-Oncology
|
March 29, 2018
Population description and clinical response assessment for spinal metastases: part 2 of the SPIne response assessment in Neuro-Oncology (SPINO) group report
Ilya Laufer, Simon S Lo, Eric L Chang, et al.
Journal of Neuro-Oncology
|
March 20, 2012
Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study
Whitney B Pope, Xin Joe Qiao, Hyun J Kim, et al.
Neuro-Oncology
|
July 18, 2020
CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design
Kurt A Jaeckle, Karla V Ballman, Martin van den Bent, et al.
Biorxiv : the Preprint Server for Biology
|
April 16, 2025
Discovery and therapeutic exploitation of Master Regulatory miRNAs in Glioblastoma
Shekhar Saha, Ying Zhang, Myron Keith Gibert, et al.
The New England Journal of Medicine
|
February 21, 2014
A randomized trial of bevacizumab for newly diagnosed glioblastoma
Mark R Gilbert, James J Dignam, Terri S Armstrong, et al.
Page
of 31